Mycenax Biotech Incorporated operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mycenax Biotech Incorporated with three other
pharmaceutical manufacturers in Asia:
of South Korea
sales of 2.81 billion Korean Won [US$2.39 million]
(102.78 million Taiwanese Dollars [US$3.24 million]
based in South Korea
(4.73 billion Korean Won [US$4.01 million]
Mycenax Biotech Incorporated reported sales of 134.86 million Taiwanese Dollars (US$4.25 million)
December of 2015.
increase of 19.3%
versus 2014, when the company's sales were 113.08 million Taiwanese Dollars.
This was the fourth straight year of sales growth at Mycenax Biotech Incorporated.